NYU Langone’s Skolnik Lab leads collaborative research studies to determine the mechanisms that regulate KCa3.1, a Ca2+-activated K+ channel that plays a role in activating B and T cells. We are investigating the potential of KCa3.1 inhibitors as novel therapies for conditions such as inflammatory bowel disease and autosomal dominant polycystic kidney disease.

Learn more about our research by reading the latest publications authored by our team.

Contact Us

Edward Y. Skolnik, MD
Principal Investigator
Professor, Departments of Cell Biology and Medicine
540 First Avenue, 3rd floor, Lab 9
New York, NY 10016
Office phone: 212-263-7458
Lab phone: 212-263-7456
Fax: 212-263-8951
Email: edward.skolnik@nyulangone.org